Category Archives: Tms

POLICE are investigating a theft which occurred on Monday, February 7 at TMS Motor Services on Clay Flatts in Workington.

The incident took place around 8:15pm, which saw two males filling up a shopping trolley of scrap metal from the sites rear yard.

A spokesperson for Cumbria Constabulary said: Both males are described as white, middle aged and of a larger build, one of the males was wearing a green jacket and a grey or white hood, dark trousers and a facemask.

"The second male was wearing a light-coloured bobble hat, dark trousers, a dark coloured hooded top and a facemask.

We are appealing for anyone with information, CCTV or dashcam footage in the area to please get in touch, they said.

Anyone with information is encouraged to contact PC 2755 on 101, quoting incident number 37, February 8. Alternatively, you can call Crimestoppers, anonymously, on 0800 555 111.

View post:

Police appeal for scrap metal thieves in Workington | News and Star - News & Star

New York, NY /PRNewswire/ - Firmament, a provider of structured equity capital solutions to small- and medium-sized enterprises (SMEs), announced today its investment in NASCENT Technology, a leading manufacturer of Automated Gate Systems (AGS), software and systems integration for the supply chain, including rail, marine terminals, manufacturing and distribution centers, as well as the private and for-hire carrier market.

The acquisition of NASCENT is a continuation of Firmament's longstanding commitment to investing in the supply chain. NASCENT is the worldwide leader and pioneer of fully integrated, scalable hardware and software for automated gates, portals, and kiosks as well as safety and security monitoring equipment. NASCENT celebrated its 26th anniversary in January and has played an instrumental role in accelerating and transforming gate and portal processes in the intermodal industry. Ted Wong, Principal at Firmament, remarked, "Our investment will allow NASCENT to invest in its suite of best-in-class technology solutions and to service its growing customer footprint during a time of unprecedented demand for improved visibility and control within the supply chain. We value the opportunity to be part of the solution for the current supply chain challenges."

NASCENT will also benefit from strategic partnership with Firmament's portfolio company, Envase Technologies, the largest and most innovative cloud-based Transportation Management System (TMS) provider for intermodal and drayage operators in North America. Since 2020, Envase's portfolio of brands has grown to include Profit Tools, Compcare Services, Tailwind Transportation Software, SecurSpace, and Infosite Technologies. The integration of data and the resulting real-time visibility from intermodal and drayage operators on-the-go through to terminals and facilities in the NASCENT footprint offer customers and partners an unmatched value proposition.

"The NASCENT team is excited by Firmament's investment and what the future holds. Firmament's knowledge and expertise within the supply chain industry will enable us to support our growing customer base and their evolving technology needs. Furthermore, our customers in the intermodal and drayage industry will greatly benefit from the strategic partnership with Envase," said Ray West, President and CEO of NASCENT. "We are eager to leverage our technologies and teams in ways that will help our customers move freight more efficiently and securely through ports, rails, yards, warehouses, and end destinations with complete visibility."

Larry Cuddy, Jr., CEO of Envase Technologies, commented, "NASCENT's market-leading technology and expertise aligns perfectly with Envase's goal to revolutionize and digitize the end-to-end lifecycle of containers. With this strategic partnership, NASCENT and Envase have a significant opportunity for technological innovation within the intermodal industry and international growth and expansion."

About NASCENT TechnologyNASCENT Technology (www.nascent.com) is the worldwide leader and pioneer in the development, manufacture, installation, and service of fully integrated, scalable hardware and software for gates, kiosks, safety, and security monitoring equipment. As one of the pioneers of Automated Gate Systems (AGS) to the industry, NASCENT has consistently led the way in new technology-based solutions, providing several innovations and industry firsts. Backed by unrivaled engineering, assembly, software development, QA, and support organizations, NASCENT continues to draw on its vast industry experience and keen focus on supply chain operations to provide unparalleled solutions.

About EnvaseEnvase (www.envasetechnologies.com) provides mission-critical, cloud-based transportation management system (TMS) enterprise software and mobile applications to the supply chain, with a core focus on the drayage trucking niche. The software merges order entry, dispatch, container tracking, electronic data interchange (EDI), API connectivity, document imaging, invoicing, settlements, and business intelligence, among other functions, into a single, streamlined system providing carrier efficiencies and container visibility over the supply chain.

About FirmamentFirmament (www.firmament.com) provides structured equity capital solutions to small- and medium-sized enterprises. Firmament is a value-added partner to entrepreneurs, management teams and business owners and curates solutions by deploying versatile capital in a user-friendly way. Firmament concentrates on software and services businesses with significant scaling potential in the healthcare, logistics, wellness and environmental sectors. With offices across the United States and in the United Kingdom, Firmament is focused on turning small business into big business.

View post:

Firmament Acquires NASCENT Technology, The Market Leader In Automated Gate Systems For The Supply Chain Industry - Supply Chain Market

Ken Jeong and Robin Thicke Walked Off from TMS!

The Masked Singer Season 7 has gained some heat in the past few days. This time, for a different reason altogether.

The judges of The Masked Singer walked off from the set afterRudy Giuliani unmasked himself during the show. This was the first episode of the show and it was taped last week.

Ken and Robin, the judges of the current season were stressed seeing Rudy on the stage. Thus, to protest, the two walked off the stage. TMS Season 7 will feature The Good, The Bad,andThe Cuddly.

What exactly went wrong and who is Rudy? Lets dive deep.

Apparently, Rudy Giuliani was one of the primary Donald Trump assistants during the 2020 elections.

The shows cast this time will feature the good, the bad, and the cuddlywhich now falls in place given Rudys disclosure. Giuliani, being one of the primary aides to Trump in 2020 brought him the trouble.

In addition to being Trumps assistant, he was involved in much more. After Trumps defeat by Joe Biden, Rudy made many false accusations and claimed voter fraud while the elections were held.

Moreover, their legal team also challenged the election result and as it was meant to be, there was no success.Nada.

Deadline reported the news first and also reported that the two judges immediately left the show and walked off after spotting Rudy.

Eventually, they did come back. On the other hand, the show led by other two judges Nicole Scherzinger and Jenny McCarty decided to be onstage. They also had a little chat with Rudy.

TMS is the show which has been doing so well for the past six seasons. Its USP is the surprise that follows when the celebrity is dumped and has to remove their masks.

Since 2020, the reaction towards Rudy was the most unwelcoming;cant say he didnt deserve it.

Earlier, the show has slapped with criticism over a different controversy aboutSarah Palin, masked as the bear.

If you are thinking, you get a spoiler here, you are right. But not entirely.

Rudys costume remains questionable and we are not going to shout out loud on that one. Also, his episode is not coming out until the next month, therefore, clearly, everyone needs to wait.

Not a lot of word about what else happened. It will be interesting to find out which category out of the three i.e. the good, the bad, and the cuddly did Rudy belong to.

The situation that happened with Ken, Robin, and Rudy is understandable. However, shows like The Masked Singer needs to stay politics-free. No one wants to ruin what shows like these have been offering for the past few seasons.

Everyone loved TMS. Everyone enjoys it to the fullest. Incidents like these are rather unexpected.

Maybe, Fox takes its lesson from what happened and avoids having such political problematic individuals in their show.

One month before you actually, see this episode. Good luck, waiting.

More:

Ken Jeong and Robin Thicke Walk Off from TMS After Seeing Rudy Giuliani - TheTealMango

[100 Pages Report] Toll Management System(TMS) Market Insights 2022 A Toll Management System (TMS) is put in place to collect revenue and recover the capital outlay incurred on the cost of construction, repairs, maintenance, expenses on toll operation by concessionaires, private organizations to provide reduced travel time and increased level to service to end user.

Market Analysis and Insights: Global Toll Management System(TMS) Market

In 2021, the global Toll Management System(TMS) market size will be USD million and it is expected to reach USD million by the end of 2027, with a CAGR of % during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Toll Management System(TMS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Toll Management System(TMS) market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Toll Management System(TMS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Toll Management System(TMS) market.

Global Toll Management System(TMS) Scope and Market Size

Toll Management System(TMS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Toll Management System(TMS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Get a Sample PDF of report https://www.360researchreports.com/enquiry/request-sample/19526941

Leading key players of Toll Management System(TMS) Market are

Toll Management System(TMS) Market Type Segment Analysis (Market size available for years 2022-2027, Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2027): On-premise, Cloud Based

Regions that are expected to dominate the Toll Management System(TMS) market are North America, Europe, Asia-Pacific, South America, Middle East and Africa and others

If you have any question on this report or if you are looking for any specific Segment, Application, Region or any other custom requirements, then Connect with an expert for customization of Report.

Get a Sample PDF of report https://www.360researchreports.com/enquiry/request-sample/19526941

For More Related Reports Click Here :

Narcolepsy Drug Market In 2022

PVC Window Profile Market In 2022

Read this article:

(New Report) Toll Management System(TMS) Market In 2022 : The Increasing use in Highway, Urban is driving the growth of the Industry across the globe ...

Historically, the RFP process has been laborious, expensive and exclusive. Shippers have aimed to work with as few carriers and brokers as possible while locking in rates on an annual basis. Over the past couple of years, market shifts and capacity constraints have illuminated the flaws in this unsustainable process.

For many years, if you talked to shippers, their whole goal was to limit the amount of carriers that had access to them. If a shipper could use one carrier for everything, they would love it. Thats just not how it works, Emerge CEO Andrew Leto said. Your average shipper in the U.S. has 15-20 carrier and broker relationships. There are 65,000 for-hire truckload carriers.

Shippers may benefit from limiting the number of partners they work with in a loose market, but this exclusionary approach has become a serious and seriously expensive problem as capacity has tightened and rates have climbed to record highs.

You have to start looking at your supply chain and knowing where your gaps are, Leto said. One of the biggest problems in this industry is the capacity matching.

Most shippers are still relying on spreadsheets and emails to deal with both spot and contract bids. At a time when shippers are being forced to run more spot bids than ever, this process can be a real liability, as it tends to be inefficient and opaque.

You have to run a bid, get new carriers, manually award the bid and then manually change the route guide in TMS, Leto said. You cant be agile doing that. Emerge will automatically change route guides in your TMS, making you much quicker and faster.

In order to thrive in the current market, Leto encourages shippers to ditch their old solutions in favor of a multifaceted, tech-savvy approach. Shippers should be taking advantage of cutting-edge visibility solutions, modern benchmarking options and a good RFP platform that works with their TMS.

The best RFP platforms, like the one offered by Emerge, not only play well with a shippers TMS, but also bring their freight out into the light, giving a wider network of carriers and brokers access to the shippers freight. This helps combat the market tightness and sky-high rates shippers have been grappling with.

When these easy-to-use RFP platforms are coupled with benchmarking tools, like FreightWaves SONAR, shippers gain even more control over their shipments. With strong benchmarking and predictive freight rates, shippers can decide whether a shorter or longer RFP is right for them at any given moment, ensuring they do not get locked into subpar rates over the long term.

Click here to learn more about how Emerge is reinventing freight procurement.

Read the original:

Old-school RFP processes are keeping shippers in the past - FreightWaves

INTERVIEW: Phil Tufnell and Jonathan Agnew will soon embark on a 20-day tour to celebrate the iconic Test Match Special programme, and England's Ashes debacle will be up for discussion

Video Unavailable

Play now

Sue Barker, Matt Dawson & Phil Tufnell to leave Question of Sport

Former England Test spinner Phil Tufnell has called for changes to be made to the county cricket calendar following the latest Ashes debacle down under.

In April and May, Tufnell, 55, will be joined by colleague Jonathan Agnew on a 20-date live Test Match Special [TMS] tour, with the iconic duo set to regale audiences with the highlights of their careers, both on the field and in the commentary box.

And in an interview with The Mirror , 'The Cat' admitted "the England shambles down in Australia might get a mention."

Tufnell himself played in 12 Ashes Tests during an international career that spanned 11 years, with one of his finest hours coming in 1997 at The Oval when he took match figures of 11-93 to secure a dramatic home victory.

Image:

However, by that point, Australia had already retained the urn and the Middlesex man was able to relate to the current crop of players during their harrowing 4-0 series defeat this winter.

"I covered some of it [The Ashes] some of it during the winter and must admit it was a tough watch at 4am in the morning," he said.

"Of course the preparation, the covid bubbles, the isolation and all that stuff - it has been very, very tough for the team. But at the end of the day we didn't perform and it's as simple as that.

"I've been on a few Ashes tours and when you get a good walloping down under everyone comes back and wrings their hands - and says we got to change this and look at structures and so have you."

Tufnell stopped short of calling for drastic change, but did identify a key area where English cricket can help its red-ball side.

"I think they have now decided to put three or four County Championship games in the middle of the summer. We need that.

"We've got to play on better pitches and we've got to play as much in middle of summer as we can.

"We can't be playing red ball at the beginning of April when snow is on the ground and you got 10 jumpers on - and everyone is getting bowled out for 100 on green decks. And we can't also be playing in October when there are leaves on the the ground.

"We're a fantastic white-ball cricketing side now but the red ball just needs a bit of TLC and looking after at the moment. And people above my pay grade are looking into how we structure it.

Image:

"Everyone loves Test cricket and wants to play it. It's the pinnacle, it just needs tinkering, not massive overhauls."

In the meantime, Tufnell will focus on his return to the live stage, albeit in a different capacity to when he was starring in pantomime and hosting A Question of Sport.

"I'm really looking forward to it [the tour] and can't believe they haven't done one beforehand.

"I've done working in the theatres and you get a great feedback from an audience. Sometimes on television you can't digress, but you can wander around a bit more on a stage or on the radio. I'm sure we'll wander down a few paths and end up in a few cul-de-sacs along the way so who knows where we're gonna end up?

"It's just going to be like a normal TMS show with a few other things thrown in along the way."

Phil Tufnell and Jonathan Agnew will be on the road with The Test Match Special Tour throughout April and May 2022. Tickets available from http://www.fane.co.uk/tms.

Read More

Read More

Link:

Phil Tufnell identifies key change to be made if England are to recover from Ashes mess - The Mirror

You sit in a comfortable chair, wearing earplugs. A clinician puts a magnetic coil on your scalp, toward the front

You sit in a comfortable chair, wearing earplugs. A clinician puts a magnetic coil on your scalp, toward the front of your head. You feel a tapping on your forehead and hear clicking sounds as the machine turns on and the transcranial magnetic stimulation, or TMS, begins.

By this point, the TMS expert physician has already determined the minimum amount of power needed to stimulate your brain cells, this will meet your individual threshold and can cause your thumb muscles to twitch. Now, the TMS technician administers the actual treatment. Your scalp may tingle as the magnetic pulses pass through to your brain.

Youre awake and alert for the half-hour or so that the procedure takes. Once treatment is done and the coil comes off your head, you leave and go about your normal daily routine.

You repeat the TMS treatment five days a week, Monday through Friday, for the next six weeks or so. The goal: That persistent depression symptoms will improve or disappear entirely. You may experience some change in symptoms after a week or two, but a typical course takes over a month to bring remission.

Not everyone with depression is a candidate for TMS. To qualify for insurance coverage in the U.S., you must have a diagnosis of major depressive disorder and already tried one or more antidepressant medications but experienced inadequate or no symptom relief.

Not everyone responds to TMS, either. But for those who do, the noninvasive treatment helps them feel better and once again be able to enjoy things and function like they did before their depression began.

[SEE: 11 Tips to Support Someone Struggling with Mental Health.]

What TMS Is

TMS is a noninvasive procedure using magnetic fields to stimulate nerve cells, or neurons, in the brain. Treatment is given through repetitive magnetic pulses, known as repetitive TMS, rTMS, or TMS therapy.

In a standard TMS session, clinicians place an electromagnetic coil on your scalp near your forehead. This coil delivers a series of magnetic pulses to stimulate neurons in the cortex brain areas involved in regulating emotions. TMS is believed to work by activating brain regions and networks that are malfunctioning when a person has persistent depression.

While its difficult to give a precise number of individual patients who receive TMS yearly, it is estimated that more than 20 million treatments have been given in the U.S. since it was approved by the Food and Drug Administration in 2008, says Dr. Linda Carpenter, a psychiatrist at Butler Hospital and a research professor in the department of psychiatry and human behavior at Brown University. Carpenter directs the Butler Hospital TMS Clinic and Neuromodulation Research Facility in Providence, Rhode Island.

Patients that qualify for TMS are those who have failed to get better with standard antidepressant medication, Carpenter says. Thats probably a third of all patients that get treated for depression.

Its important not to confuse TMS with the electricity-based treatment called electroconvulsive therapy, or ECT, although both are used for treatment-resistant depression. ECT uses electrical currents, rather than the magnetic fields that TMS uses. ECT causes a brief, controlled seizure that affects neurons and brain chemicals as its treatment goal. By contrast, TMS therapy activates targeted brain areas, and patients are awake and aware throughout.

Unlike some other forms of brain stimulation, TMS does not require implanted electrodes or surgery. Nor does TMS require anesthesia, unlike ECT.

[See: 7 Signs of Depression in Men.]

Who It Treats

Devices capable of delivering transcranial magnetic stimulation to the human brain were first developed in 1985.

In 2008, the FDA approved TMS for adults with depression thats resistant to standard treatments. Specifically, its currently approved for whats called primary major depressive disorder without psychotic symptoms, Carpenter says. Psychotic symptoms relate to being out of touch with reality, such as hallucinations or delusions. The depressive syndrome for which TMS is approved is characterized by a certain number of symptoms that persist for weeks: depressed or low mood, loss of ability to experience pleasure and problems with sleeping, appetite, interests, concentration and motivation. Sometimes anxiety is also a symptom.

TMS represents a significant therapeutic option for people in need. It plays a really important role in what we refer to as treatment-resistant depression,' says Dr. Alexander McGirr, principal investigator for the McGirr Lab, part of the Hotchkiss Brain Institute of the University of Calgary in Alberta, Canada.

In Canada, our guidelines advocate that after a single failed antidepressant, you should be considering TMS, McGirr says. Because it has a different mechanism of action, youre more likely to get benefit from it than you would be from switching to a different medication.

In 2018, the FDA approved TMS to treat obsessive-compulsive disorder, or OCD. In 2020, TMS was approved as a smoking cessation therapy.

Researchers have investigated rTMS for a variety of brain-based disorders, such as relapsing multiple sclerosis and Parkinsons disease. However, most of these are not FDA-approved indications.

Patient Experience

The Butler Hospital Clinic treats about 100 new patients a year, along with many returning patients, Carpenter says. Sometimes the patients will get better and then come back again a couple years later, or at some point in the future, to get a repeat course of treatment if their depression comes back, she says.

Carpenter describes how TMS works: Magnetic energy passes through your scalp and your skull tissues, she says. Its pulsed from a little device called a coil that sits on your head. When magnetic pulses reach the brain tissue called the cortex, the outer layer of the brain, it induces current activation. Your neurons conduct electricity and this induces electrical current in the neurons located under the coil. These neurons produce electricity and use it to send signals to neurons in other areas of the brain, so there is communication through brain networks.

According to patient feedback, Carpenter says, The first day of TMS might feel like theres a woodpecker pecking on your head. Theres percussion or tapping sensation when the pulses are delivered to the patients head. Sometimes theres a little bit of a twitching in the muscles around the forehead, and scalp around the coil, because TMS can activate nerves to some of those muscles we use to raise our eyebrows or make facial expressions.

Most patients become accustomed to TMS after a couple sessions. The sensation is diminished and they dont feel that much, Carpenter says. Sometimes it feels sort of soothing and people get drowsy during the stimulation; they get used to it. Your brains awareness of the sensation tunes down and accommodates to it, so it doesnt really feel like much after youve had a few sessions.

TMS Effects

TMS effects can be measured both in the area of the brain directly beneath the coil, called the prefrontal cortex, as well as through connections or relationships with other areas of the brain that are deeper and further back, Carpenter explains.

It doesnt take long for patients to start seeing results. During the first week, they might have a little more energy than before, Carpenter says. After a week or two of daily TMS, patients start to notice: Gee, Im more interested in things, I have more energy and Im concentrating better.' For the Butler clinic, Carpenter notes, We usually see gradually accumulating symptom improvement over the weeks.

Of his TMS patients, McGirr says, When it works, its really quite remarkable. About 25% experience an extremely rapid response. Sometimes theyll use metaphors: Its like a light went on and they see the light again, he says. And they feel much better.

About half of patients have a gradual, progressive improvement, McGirr says. They describe it as a slow improvement and they didnt really notice it much, at first, he says. Then they started to notice things at the two-to-four week mark. Changes continue, with other people in patients lives commenting on the difference.

However, some patients dont have improvement even after daily TMS treatment for up to six weeks. Unfortunately, there are those people who do not benefit from this treatment and that can be a little bit frustrating, because it is a fairly demanding treatment, McGirr says.

Types of TMS

Various TMS devices deliver magnetic brain stimulation using different treatment protocols. These include:

Repetitive transcranial magnetic stimulation. As described above, rTMS is the established version. Typically, it involves high-frequency stimulation to the brains prefrontal cortex.

Intermittent theta burst stimulation. Also called iTBS, this newer form of rTMS is also FDA-approved for stimulating the cortex in once-daily sessions. A course of therapy requires the same number of weeks, but each session is shorter because magnetic pulses are delivered very quickly.

[READ: 7 Tips for Living With Depression.]

Side Effects

During TMS treatment, while attached to the coil, patients may experience side effects including:

Headache.

Facial muscle tingling or twitching.

Scalp discomfort or irritation.

Lightheadedness or dizziness.

Hearing loss (preventable by proper earplug use).

Rare but serious side effects may include:

Seizures.

Mania in people with bipolar disorder.

Although the risk of seizures with TMS treatment is less than 1% overall, it does exist, according to an evidence review published in December 2020. Proper screening to rule out TMS treatment for individuals at increased seizure risk is an important step in prevention, according to an April 2020 National Institute of Mental Health expert lecture on TMS risks and safety.

Adding TMS to the Treatment Arsenal

Medication and psychotherapy, or talk therapy, are first-line treatments for depression. However, access to talk therapy can be difficult with only a limited number of sessions covered by insurance. Antidepressant medications work for many people, but they may cause burdensome side effects in others.

For example, the most frequently prescribed class of antidepressants is the selective serotonin reuptake inhibitors. Agitation and anxiety, sexual problems like low libido, dizziness, headaches, nausea, diarrhea, insomnia and tremor can all be SSRI side effects.

Even among those who originally respond to antidepressant medications, the effectiveness can wane over time. Alternatives or adjuncts may be needed to fill treatment gaps.

The advantage of TMS is that its a fundamentally different way of treating the depression, whereas a lot of our medications have common mechanisms of action, McGirr says. So, we know that when switching (from one depression medication) to the next, you get vanishingly smaller return for your investment with each step you go.

By contrast, moving to TMS may make a notable impact. Switching to something that works entirely differently so actually trying to drive plasticity in the parts of the brain related to depression we can try to get at the neurocircuitry thats changed with depression and try to restore it, McGirr says. In other words: Were trying to make the brain work the way it did before depression.

Oftentimes, patients treated with TMS continue to take their antidepressant medications. We usually recommend that people stay on their medications because they have gotten some effect, and the medications themselves have a variety of effects on the brain that could potentially be healing of the brain, McGirr says.

Evaluation for Treatment

Patients considering TMS typically undergo a physical and psychiatric evaluation to determine if the treatment is safe and appropriate for them. Clinicians will also ask patients other medical conditions, pregnancy, medications or supplements they take, and alcohol and substance use among other information.

Reasons that patients may not be recommended to receive TMS include:

Having implanted devices such as heart stents, aneurysm clips or coils, implanted stimulators or electrical medical devices like a pacemaker or a cardioverter-defibrillator, cochlear hearing implants, bullet fragments or other nonremovable metal implants inside the body within a few feet of the head. Dental metal is not a problem.

Seizure history or epilepsy.

Brain illness or significant history of brain injury, such as a stroke, brain tumor or traumatic brain injury.

Data: Does TMS Help?

A growing body of evidence finds TMS effective for patients with major depressive disorder that hasnt responded well to standard treatments.

A randomized clinical trial with data supporting TMS treatment was published in 2007, showing about 24% of depressed patients responded to the treatment. A subsequent trial, funded by the NIMH, was published in May 2010. During the first study phase, about 15% of participants achieved remission a symptom-free period in their depression. During the second study phase, nearly 30% experienced remission.

A meta-analysis of 81 studies encompassing nearly 4,250 patients treated with various types of TMS, published in February 2017 in JAMA Psychiatry, found all types more effective, and at least as tolerable, as sham (placebo) TMS treatment for major depressive episodes.

The Three-D study, published in April 2018 in The Lancet, which compared rTMS and iTBS, found them equally safe, tolerable and effective in treating patients with major depressive disorders.

A meta-analysis of 10 studies encompassing nearly 700 patients, published in May 2021 in the journal Translational Psychiatry, found a similar, positive effect rates for both rTMS and theta burst stimulation compared to sham TMS treatment for major depressive disorder.

A small study of a new, intensive form of TMS called Stanford neuromodulation therapy, published in October 2021 in the American Journal of Psychiatry, found rapid improvement in nearly 80% of the 29 participants, all with severe, treatment-resistant depression. This form of TMS, which involves 10 TMS sessions per day, will be evaluated in large clinical trials to determine if it is suitable for standard TMS practice.

A study of 700 U.S. military veterans, appearing in the January 2022 issue of the Journal of Affective Disorders, found TMS was effective in treating veterans with major depressive disorder, including participants with symptoms of posttraumatic stress disorder.

Its unclear whether TMS works for different forms of depression. For instance, a randomized clinical trial of 37 patients with bipolar depression, led by McGirr and published in March 2021 in JAMA Network Open, did not find theta burst stimulation more effective than sham TMS. Bipolar depression is characterized by periods of mania as well as depression, unlike the unipolar depression for which TMS treatment is approved.

Seeking TMS

If youre looking into TMS for depression, choose the treatment facility carefully and ask questions. The main thing that patients want to look for is a practice with doctors and clinic staff that are providing evidence-based care, Carpenter says.

There are a lot of different brain regions and a lot of different stimulation protocols that could be used in TMS care, Carpenter says. But you want to find a doctor and a clinic that will deliver a published, scientifically sound stimulation protocol. And its important that patients look for a clinic where TMS physicians are prescribing the stimulation and day-to-day monitoring is done by TMS clinicians who are skilled and trained.

Check your insurance coverage. For a regular course of TMS therapy to treat depression, all insurance companies now and federal payers Medicare/Medicaid all cover a course of TMS to treat depression, Carpenter says. Many policies have different criteria and they require that you have failed a certain number of antidepressant medication trials. Policies describing coverage criteria for TMS practice have changed over time as the evidence base has evolved. At this point, TMS coverage is fairly good for appropriate candidates, but not every person who could benefit lives near a TMS clinical practice.

Its not too soon to consider TMS if youre suffering from depression without relief, McGirr says. This is something that should be on the table as soon as any first-line intervention any medication trials have failed or any psychotherapy has failed and somebody is having continuing depression and they have not responded to some of our best treatments, he says. (TMS) is something that should be in the discussion early.

More from U.S. News

What to Know About Anxiety Medications

Questions Doctors Wish Their Patients Would Ask

Tips to Manage Stress at Work

What Is TMS Treatment for Depression? originally appeared on usnews.com

See original here:

What Is TMS Treatment for Depression? - WTOP

Enlarge photo.

Tonganoxie school district officials are continuing to look into the practicality of installing artificial turf at Beatty Field. USD 464 board members met with Superintendent Loren Feldkamp and Assistant Superintendent Tonya Phillips and school administrators during a special meeting Monday in the Tonganoxie High School library.After a lengthy discussion about the merits of turf and how it should be handled as a priority with improving district facilities, the board agreed to look at the possibility of fundraising and the forming of a committee.

Tonganoxie USD 464 will be requiring masks in campus buildings for the next two weeks.

Per information the district released Thursday evening, the mask requirement begins Friday and will continue for two weeks after district officials reviewed current COVID-19 numbers.

The district had 30 positive cases 26 students and four adults a few days after classes resumed after winter break. There also were 47 students in quarantine and one adult in quarantine as of Thursday.

Student cases by school are 11 at Tonganoxie High School, six at Tonganoxie Middle School and nine at Tonganoxie Elementary School. The adult cases are two at TES and two at TMS. As for quarantined students, 29 are from TES, three from TMS and 15 from THS. Theres also one adult at TES quarantining.

The number of cases more than doubled since Tuesday when there were seven positive student cases at TES and six at TMS. There were no positive cases at THS, though students had a remote learning day, so Wednesday marked the first day when students returned to in-person instruction.

Read more:

Tonganoxie USD 464 moves back to required masks for 2 weeks | TonganoxieMirror.com - The Mirror

Treatments for clinical depression and anxiety range from medication to psychotherapy, but there is a new, experimental treatment in consideration by researchers as of late: magic mushrooms.

A study published November 4, 2020, by Johns Hopkins Bayview Medical Center researchers from the Center for Psychedelic and Consciousness Research in Baltimore, Maryland found that psilocybin (more commonly known as magic mushrooms), when given in conjunction with psychotherapy, decreased depressive symptoms in participants.

This study, conducted in 2017 and 2019 at Johns Hopkins, consisted of 24 participants who had long-term histories of depression. They received doses of psilocybin and followed up with researchers one week and four weeks after receiving the treatment. Most participants showed improvement and half ended up achieving remission essentially depression-free or at least symptomless when followed up with four weeks after receiving the experimental treatment.

Researchers at Johns Hopkins have also conducted studies over the years that have found psilocybin decreases cancer-related anxiety in cancer patients and may lead to helping smokers quit and treatments for alcohol abuse.

But Johns Hopkins is not the only place where psilocybin research is being centered when it comes to treating various psychological disorders.

Compass Pathways, which is an organization that is dedicated to accelerating patient access to evidence-based innovation in mental health, ran a study this year with over 200 participants that also showed marked improvement in the symptoms of people receiving psilocybin treatment as opposed to a control group that received a placebo.

Some states are legalizing psilocybin for therapeutic use. In 2020, following the release of the results from the Hopkins study, the state of Oregon legalized it and laid out plans for its therapeutic use. On a federal level, though, psilocybin continues to be considered a Schedule I drug, meaning it is a drug with no currently accepted medical use and a high potential for abuse, according to the United States Drug Enforcement Administration. Other examples of these include marijuana, peyote, and heroin.

Furthermore, these treatments are new and still in the process of being researched, in spite of their success in studies like the one at Hopkins. They are not yet readily accessible, and experts warn about potential adverse effects and lack of in-depth research, saying not to try psilocybin as a means of treating depression just yet.

In a blog post, Psych Atlantas medical director Dr. Michael Banov pointed out the risks and unknowns associated with psilocybin as a treatment for mental health problems. He mentions many reasons, including the fact that the substance is currently illegal you could not receive a prescription for it and the complexity of using treatments we do not yet know much about the side effects of or whether there are interactions with other medications, etc.

Its too risky now, Dr. Banov writes. We dont know if it could make certain patients mental health worse or be dangerous with some medications, medical conditions, or supplements you are taking. If youre looking for treatment alternatives, stick with those with a longer track record and are legal, such as medication combination therapies, off-label medicines that have been shown to be helpful, Transcranial Magnetic Stimulation (TMS), ketamine or Spravato, or natural supplements.

Symptoms of clinical depression or major depressive disorder (MDD) include persistent feelings of sadness or emptiness, feelings of worthlessness or pessimism, fatigue, trouble concentrating, loss of interest, and crankiness, among many other behavioral and emotional responses.

Continue reading here:

Psilocybin Could Be Next Frontier for Depression and Anxiety Treatment - Georgia Voice

A research team in Sweden found TMS could be an effective option for treatment of alcohol addiction.

The Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linkping University, Sweden, has released a study in which deep, repetitive transcranial magnetic stimulation (TMS) showed promise for the treatment of alcohol addiction. The findings were published in the December 5 online edition of Biological Psychiatry.

The team noted, Alcohol addiction is associated with a high disease burden, and treatment options are limited. In a proof-of-concept study, we used deep repetitive transcranial magnetic stimulation (dTMS) to target circuitry associated with the pathophysiology of alcohol addiction. We evaluated clinical outcomes and explored associated neural signatures using fMRI.

In the trial study, the researchers enrolled and randomly assigned 51 treatment-seeking adults with moderate to severe alcohol dependence to receive an active or placebo treatment. Beforehand, these individuals completed craving induction, which included holding and smelling but not consuming an alcoholic beverage, the team reported.

The randomized, double-blind, placebo-controlled trial offered study participants TMS targeting the medial prefrontal cortex (mPFC) and anterior cingulate cortex (ACC) for three weeks. The results shows that the treatment significantly reduced heavy drinking days compared to a group of participants who received a placebo treatment. The team reported TMS is safe and effective in decreasing symptoms of alcohol addiction and brain reactivityThe active treatment group also reported significantly less alcohol craving and showed less functional connectivity on MRI in areas of the brain that can trigger craving and relapse.

Clinicians should keep their eyes open in the wake of this phase 2 trial, said co-corresponding author Markus Heilig, MD, PhD, professor of psychiatry and director at the Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linkping University, Sweden. He added, If and when this replicates in the equivalent of a phase 3 study, we will actually have a completely novel treatment available for this difficult to treat and very impactful disease.

Heilig explained that before stimulating the brain, you want to make it as malleable as possible; and brain networks tend to be more malleable when they are active. This is why the holding and smelling of the alcoholic drink was key before proceeding with TMS or the placebo.

During the three-week treatment, active or sham stimulations were delivered in five 30-minute sessions per week, the study notes. During the sessions, all participants wore a helmet with a deep TMS coil produced by BrainsWay.

In the active stimulation group, each session included 100 trains of 30 pulses at 10Hz (3 seconds) with 15-second intervals, for a total of 3000 pulses. The sham stimulation produced the same acoustic artifact and generated skin sensations mimicking those of the active stimulation, but it did not involve a magnetic field. Participants, operators, and raters were blinded to the type of coil used, according to the research team.

Five participants had to be eliminated from treatment due to relapsing during the three-week trial. Two-thirds of participants were males and Heilig noted that the gender makeup reflects what a real treatment-seeking group looks like.

Repetitive transcranial magnetic stimulation in alcohol dependence: A randomized, double-blind, sham-controlled proof-of-concept trial targeting medial prefrontal and anterior cingulate cortex

Transcranial Magnetic Stimulation Shows Promise for Alcohol Addiction

Continue reading here:

TMS Therapy is 'Promising' for Alcohol Treatment - Legal Reader